Oncotarget

Research Papers:

Hypoxia promotes Rab5 activation, leading to tumor cell migration, invasion and metastasis

Patricio Silva, Pablo Mendoza, Solange Rivas, Jorge Díaz, Carolina Moraga, Andrew F.G. Quest and Vicente A. Torres _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:29548-29562. https://doi.org/10.18632/oncotarget.8794

Metrics: PDF 1376 views  |   HTML 1379 views  |   ?  


Abstract

Patricio Silva1, Pablo Mendoza1, Solange Rivas1, Jorge Díaz1, Carolina Moraga1, Andrew F.G. Quest2,3, Vicente A. Torres1,2

1Institute for Research in Dental Sciences, Faculty of Dentistry, Universidad de Chile, Santiago, Chile

2Advanced Center for Chronic Diseases (ACCDiS), Faculty of Medicine, Universidad de Chile, Santiago, Chile

3Center for Molecular Studies of the Cell (CEMC) and Program of Cell and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile

Correspondence to:

Vicente A. Torres, e-mail: vatorres@med.uchile.cl

Keywords: Rab5, hypoxia, migration, metastasis, tumor

Received: November 10, 2015     Accepted: March 28, 2016     Published: April 18, 2016

ABSTRACT

Hypoxia, a common condition of the tumor microenvironment, is associated with poor patient prognosis, tumor cell migration, invasion and metastasis. Recent evidence suggests that hypoxia alters endosome dynamics in tumor cells, leading to augmented cell proliferation and migration and this is particularly relevant, because endosomal components have been shown to be deregulated in cancer. The early endosome protein Rab5 is a small GTPase that promotes integrin trafficking, focal adhesion turnover, Rac1 activation, tumor cell migration and invasion. However, the role of Rab5 and downstream events in hypoxia remain unknown. Here, we identify Rab5 as a critical player in hypoxia-driven tumor cell migration, invasion and metastasis. Exposure of A549 human lung carcinoma, ZR-75, MDA-MB-231 and MCF-7 human breast cancer and B16-F10 mouse melanoma cells to hypoxia increased Rab5 activation, followed by its re-localization to the leading edge and association with focal adhesions. Importantly, Rab5 was required for hypoxia-driven cell migration, FAK phosphorylation and Rac1 activation, as shown by shRNA-targeting and transfection assays with Rab5 mutants. Intriguingly, the effect of hypoxia on both Rab5 activity and migration was substantially higher in metastatic B16-F10 cells than in poorly invasive B16-F0 cells. Furthermore, exogenous expression of Rab5 in B16-F0 cells predisposed to hypoxia-induced migration, whereas expression of the inactive mutant Rab5/S34N prevented the migration of B16-F10 cells induced by hypoxia. Finally, using an in vivo syngenic C57BL/6 mouse model, Rab5 expression was shown to be required for hypoxia-induced metastasis. In summary, these findings identify Rab5 as a key mediator of hypoxia-induced tumor cell migration, invasion and metastasis.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 8794